🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
This study adopts a randomized, open label, placebo-controlled, multicenter...
Status
Recruiting
Location
The First Affiliated Hospital of USTC Anhui Provincial Hospital
Start Date
2025-12-02
Trial ID
NCT07165951
In recent years, with the emergence of various new targeted and immunothera...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2024-07-01
Trial ID
NCT06441019
Treatments Being Tested
The TQB2868 protein in this study targeted programmed cell death protein 1 ...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2022-04-27
Trial ID
NCT05198505
Treatments Being Tested
This is a Phase II, open-label, Single-center platform study research based...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2023-03-30
Trial ID
NCT05749588
Treatments Being Tested
To evaluate the efficacy and safety of TQB2868 injection combined with anlo...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2024-03-19
Trial ID
NCT06767813
Treatments Being Tested
This study used a single-arm, open phase II multicenter trial design. All e...
Status
Withdrawn
Location
Chongqing University Cancer Hospital
Start Date
2023-08
Trial ID
NCT05998941